Abstract
The blood-brain barrier is the structure that maintains central nervous system homeostasis; it is composed of brain endothelial cells, astroglia, pericytes, microglia, and of the extracellular matrix components basal lamina and glycocalyx. The blood-brain barrier constitutes the main interface between the brain and the periphery; therefore it is the main structure regulating the passage of molecules from blood-to-brain and vice versa. At brain endothelial cells are expressed numerous members of the solute carrier (SLC) and ATP-binding cassette (ABC) gene families; those carriers exert selective transport and preclude free exchange of molecules from blood-to-brain. In addition, brain endothelial cells present low paracellular diffusion and vesicle-mediated transport. The regulation of the blood-brain barrier permeability is essential to guarantee nutrient supply to brain cells, but also to allow selective passage of drugs designed to treat brain diseases. This review describes both the pharmacological and physiological approaches to modulate the permeability of the blood-brain barrier. Finally we propose that once more data on blood-brain barrier normal physiology are obtained, health professionals will be able to take advantage of normal variations in blood-brain barrier permeability to administer drugs aimed to affect the central nervous system in the critical time window of blood-brain barrier “opening”.
Keywords: blood-brain barrier permeability, brain endothelial cells, caveolae, receptor-mediated endocytosis, carrier systems, tight junctions, Beta-catenin, homotypically, paracellular leukocyte, lipophilic, neovascularization, abluminal, Plasminogen, diencephalon, dementia.
Current Psychopharmacology
Title:From Blood-to-Brain: Regulating the Permeability of the Blood-Brain Barrier
Volume: 1
Author(s): B. Gomez-Gonzalez, K. Sanchez-Alegria and J. Velazquez-Moctezuma
Affiliation:
Keywords: blood-brain barrier permeability, brain endothelial cells, caveolae, receptor-mediated endocytosis, carrier systems, tight junctions, Beta-catenin, homotypically, paracellular leukocyte, lipophilic, neovascularization, abluminal, Plasminogen, diencephalon, dementia.
Abstract: The blood-brain barrier is the structure that maintains central nervous system homeostasis; it is composed of brain endothelial cells, astroglia, pericytes, microglia, and of the extracellular matrix components basal lamina and glycocalyx. The blood-brain barrier constitutes the main interface between the brain and the periphery; therefore it is the main structure regulating the passage of molecules from blood-to-brain and vice versa. At brain endothelial cells are expressed numerous members of the solute carrier (SLC) and ATP-binding cassette (ABC) gene families; those carriers exert selective transport and preclude free exchange of molecules from blood-to-brain. In addition, brain endothelial cells present low paracellular diffusion and vesicle-mediated transport. The regulation of the blood-brain barrier permeability is essential to guarantee nutrient supply to brain cells, but also to allow selective passage of drugs designed to treat brain diseases. This review describes both the pharmacological and physiological approaches to modulate the permeability of the blood-brain barrier. Finally we propose that once more data on blood-brain barrier normal physiology are obtained, health professionals will be able to take advantage of normal variations in blood-brain barrier permeability to administer drugs aimed to affect the central nervous system in the critical time window of blood-brain barrier “opening”.
Export Options
About this article
Cite this article as:
Gomez-Gonzalez B., Sanchez-Alegria K. and Velazquez-Moctezuma J., From Blood-to-Brain: Regulating the Permeability of the Blood-Brain Barrier, Current Psychopharmacology 2012; 1 (3) . https://dx.doi.org/10.2174/2211556011201030214
DOI https://dx.doi.org/10.2174/2211556011201030214 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Proteomics Analysis of CA1 Region of the Hippocampus in Pre-, Progression and Pathological Stages in a Mouse Model of the Alzheimer’s Disease
Current Alzheimer Research Synthesis, Molecular Docking and Antiamnesic Activity of Selected 2- Naphthyloxy Derivatives
Medicinal Chemistry Curcumin-glucoside, A Novel Synthetic Derivative of Curcumin, Inhibits α-Synuclein Oligomer Formation: Relevance to Parkinson's Disease
Current Pharmaceutical Design Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease
Current Genomics Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Current Pharmaceutical Design Antioxidants and Neuroprotection in the Adult and Developing Central Nervous System
Current Medicinal Chemistry A Prospective Study for Introducing Insulin Pens and Safety Needles in a Hospital Setting. The SANITHY Study
Current Diabetes Reviews Should Percutaneous Coronary Intervention be the Standard Treatment Strategy for Significant Coronary Artery Disease in all Octogenarians?
Current Cardiology Reviews Editorial (Thematic Issue: Ceramics, Nanotubes, Advanced Materials: Theoretical and Experimental Structure-Property Relationships: Part V)
Current Physical Chemistry Neuroprotective Strategies in Glaucoma
Current Pharmaceutical Design Alterations in the Expression of Amyloid Precursor Protein Cleaving Enzymes mRNA in Alzheimer Peripheral Blood
Current Alzheimer Research Inhibitors and Breakers of Advanced Glycation Endproducts (AGEs): A Review
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents A Review on the Effects of Testosterone Supplementation in Hypogonadal Men with Cognitive Impairment
Current Drug Targets Potential Therapeutic Effects of Exogenous Ketone Supplementation for Type 2 Diabetes: A Review
Current Pharmaceutical Design Lipophilic Analogs of Thioflavin S as Novel Amyloid-Imaging Agents
Current Alzheimer Research Effects of Exercise and Ferulic Acid on Alpha Synuclein and Neuroprotective Heat Shock Protein 70 in An Experimental Model of Parkinsonism Disease
CNS & Neurological Disorders - Drug Targets Implication of Rho GTPases in Neurodegenerative Diseases
Current Drug Targets Filling the Gaps in the Aβ Cascade Hypothesis of Alzheimers Disease
Current Alzheimer Research Adrenomedullin Function in Vascular Endothelial Cells: Insights from Genetic Mouse Models
Current Hypertension Reviews Damaged Proteins Bearing L-Isoaspartyl Residues and Aging: A Dynamic Equilibrium Between Generation of Isomerized Forms and Repair by PIMT
Current Aging Science